ARTICLE | Editor's Commentary
AZ investors aren’t buying it — neither am I
It’s hard to see any strategic sense in the rumored merger of AstraZeneca and Bristol Myers: a Perspective
August 4, 2026 12:31 AM UTC
By now everyone has seen the reports that AstraZeneca and Bristol Myers Squibb have been in talks about a merger. I don’t think I’ve been this shocked by biopharma news in a long time.
First off, it isn’t really news. At least not yet. These sorts of rumors could be leaked for multiple reasons. ...